LSA Global
JULY 6, 2024
Net Promoter Score This global biotech leader is shifting strategic growth plans and requires its top leaders to successfully design and build high performing teams that are aligned with a culture of accountability , a relentless focus on delivering results, a cross-functional mindset, and quality decision-making.
Kotter Inc.
SEPTEMBER 23, 2024
As Starbucks and Chipotle navigate CEO transitions, Nick Petschek of Kotter shares how organisations can empower their leaders during leadership changes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Kotter Inc.
MARCH 17, 2025
The post Building Adaptability in the Pharmaceutical Industry appeared first on Kotter International Inc.
Kotter Inc.
FEBRUARY 13, 2025
The post Beyond the deal: unlocking sustainable success in pharma M&A appeared first on Kotter International Inc.
Kotter Inc.
APRIL 24, 2025
For more than two decades, the pace of change has been accelerating, and with it, the complexity leaders must navigate. We are experiencing a sharp surge in uncertaintythe highest since the onset of the Covid-19 pandemic. But todays turbulence is not an isolated moment; its part of a long-building trend.
Kotter Inc.
FEBRUARY 13, 2025
After the pharmaceutical industrys muted mergers and acquisitions (M&A) landscape in 2024, Nick Petschek, EMEA MD at Kotter International suggests many expect M&A to pick back up in 2025.
Kotter Inc.
NOVEMBER 25, 2024
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Gaurav Gupta, managing director and head of R&D at Kotter, details the types of regulatory pressures and factors surrounding rising R&D costs that will affect the pharmaceutical industry.
Expert insights. Personalized for you.
36 
Let's personalize your content